skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines voretigene neparvovecQuestion & answer

voretigene neparvovec · Medicine question

Is genetic testing required before voretigene neparvovec?

iatroX medicinesPublished 22 August 2026Reviewed 22 August 2026

The answer

Answer

Yes. The licensed indication requires confirmation of biallelic RPE65 mutations.

Sources for this answer

Luxturna concentrate and solvent for solution for injectionemc · SmPC Current selected SmPC · Version 9

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

voretigene neparvovec

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the voretigene neparvovec guide

More questions about voretigene neparvovec

Who is eligible for voretigene neparvovec?Can voretigene neparvovec restore normal vision?Why must viable retinal cells remain before voretigene neparvovec is used?Is voretigene neparvovec a tablet or an eye injection?Can children receive voretigene neparvovec?Why are corticosteroids used with voretigene neparvovec?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX